Next-Generation Biotech Technologies

---

Our real-time PCR curve analysis is powered by a proprietary AI system that has been meticulously trained to interpret amplification curves with clinical-grade reliability. While we do not disclose the exact mathematical formulations, network architectures, or full training datasets for competitive and regulatory reasons, here is a high-level, conceptual overview of how the procedure works:

Raw Fluorescence Signal Acquisition: During each PCR cycle, the instrument captures multi-channel fluorescence intensity values across all wells in near-continuous time. These raw time-series signals form the input to the analysis pipeline.

Pre-processing & Signal Conditioning: The system applies a series of deterministic, hardware-accelerated filters and corrections (baseline drift removal, noise suppression, well-to-well normalization, background subtraction) to produce clean, standardized amplification curves ready for intelligent interpretation.

AI-Driven Holistic Curve Evaluation: Instead of relying solely on traditional threshold-crossing (Ct) methods, a purpose-built AI model—trained extensively on millions of real-world amplification curves collected from active CLIA-certified laboratories—examines the entire shape and behavior of each curve. The model has learned to recognize subtle patterns that distinguish:

• True positive amplification
• Late or weak true positives
• Primer-dimers and other non-specific products
• Inhibited reactions
• Failed or aborted curves
• Artifacts from optical or thermal irregularities
• This training corpus includes anonymized, consented data from thousands of patient samples, quality-control runs, validation panels, and edge-case scenarios encountered across our network of deployed labs.

Multi-Modal Confidence Scoring: The AI generates a probabilistic confidence score for each well, combining:

• Morphological features of the full curve trajectory
• Cycle-by-cycle dynamics
• Comparison against learned “normal” and “abnormal” archetypes
• Contextual information (e.g., multiplex channel relationships, replicate consistency)
• Curves are classified into clear positive, clear negative, indeterminate/requires review, or instrument failure categories—with associated confidence levels that guide automatic calling or flagging for human review.

Real-Time & Post-Run Decision Integration: Because the model runs in parallel on embedded accelerators, preliminary calls can be made during the run (enabling very early detection of strong positives). Final, highest-confidence interpretations are locked after completion, and all results are automatically uploaded to the LIS with full audit trail, curve overlays, and explainability metadata (highlighting which curve features most influenced the decision).

Continuous Learning Feedback Loop: When lab directors or pathologists override or annotate results, those expert corrections are securely fed back (anonymized and aggregated) into our model refinement pipeline. This ongoing exposure to active, diverse CLIA lab data ensures the AI remains adaptive to evolving assay chemistries, new pathogens, sample types, and instrument behaviors.

In essence, our curve analysis moves beyond rigid rule-based Ct determination to a deeply learned, shape-aware understanding of what “true amplification” really looks like—trained directly on the messy, real-world complexity of thousands of active diagnostic laboratories. This approach delivers markedly higher sensitivity and specificity, fewer ambiguous calls, and faster confident reporting, all while preserving full traceability and CLIA compliance.

We view this as a foundational shift: from algorithmic thresholding to intelligent pattern recognition that mirrors—and in many cases surpasses—the nuanced judgment of experienced molecular diagnosticians.